Wanbangde Pharmaceutical Holding Group Co Ltd
SZSE:002082
Intrinsic Value
Wanbangde Pharmaceutical Holding Group Co., Ltd. engages in non-ferrous metal industry. [ Read More ]
The intrinsic value of one Wanbangde Pharmaceutical Holding Group Co Ltd stock under the Base Case scenario is 8.36 CNY. Compared to the current market price of 4.95 CNY, Wanbangde Pharmaceutical Holding Group Co Ltd is Undervalued by 41%.
Valuation Backtest
Wanbangde Pharmaceutical Holding Group Co Ltd
Run backtest to discover the historical profit from buying and selling Wanbangde Pharmaceutical Holding Group Co Ltd stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Wanbangde Pharmaceutical Holding Group Co Ltd
| Current Assets | 2.2B |
| Cash & Short-Term Investments | 317.1m |
| Receivables | 1.2B |
| Other Current Assets | 650.1m |
| Non-Current Assets | 2.2B |
| Long-Term Investments | 11.9m |
| PP&E | 1.4B |
| Intangibles | 582.1m |
| Other Non-Current Assets | 176.5m |
| Current Liabilities | 1.4B |
| Accounts Payable | 236m |
| Accrued Liabilities | 21.8m |
| Short-Term Debt | 958.6m |
| Other Current Liabilities | 171.4m |
| Non-Current Liabilities | 389.3m |
| Long-Term Debt | 150.8m |
| Other Non-Current Liabilities | 238.4m |
Earnings Waterfall
Wanbangde Pharmaceutical Holding Group Co Ltd
|
Revenue
|
1.6B
CNY
|
|
Cost of Revenue
|
-885.7m
CNY
|
|
Gross Profit
|
735m
CNY
|
|
Operating Expenses
|
-746.4m
CNY
|
|
Operating Income
|
-11.3m
CNY
|
|
Other Expenses
|
-50.1m
CNY
|
|
Net Income
|
-61.4m
CNY
|
Free Cash Flow Analysis
Wanbangde Pharmaceutical Holding Group Co Ltd
Profitability Score
Profitability Due Diligence
Wanbangde Pharmaceutical Holding Group Co Ltd's profitability score is 35/100. The higher the profitability score, the more profitable the company is.
Score
Wanbangde Pharmaceutical Holding Group Co Ltd's profitability score is 35/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Wanbangde Pharmaceutical Holding Group Co Ltd's solvency score is 56/100. The higher the solvency score, the more solvent the company is.
Score
Wanbangde Pharmaceutical Holding Group Co Ltd's solvency score is 56/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Wanbangde Pharmaceutical Holding Group Co Ltd
Shareholder Return
Price
Wanbangde Pharmaceutical Holding Group Co Ltd
| Average Annual Return | 1.99% |
| Standard Deviation of Annual Returns | 30.73% |
| Max Drawdown | -76% |
| Market Capitalization | 3B CNY |
| Shares Outstanding | 611 689 000 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Wanbangde Pharmaceutical Holding Group Co., Ltd. engages in non-ferrous metal industry. The company is headquartered in Taizhou, Zhejiang and currently employs 1,454 full-time employees. The company went IPO on 2006-11-20. The firm conducts its businesses primarily through five segments. The Pharmaceutical Business segment is mainly engaged in the research and development, production and sales of modern Chinese medicines, chemical raw materials and chemical preparations. The Medical Device segment is mainly engaged in the research and development of medical devices, medical device services and provision of hospital engineering services. The Aluminum Products segment is mainly engaged in the manufacture and processing of aluminum products. The Metallic Coatings segment is mainly engaged in the production of powder coatings. The Other segment is principally engaged in the business of trading.
Contact
IPO
Employees
Officers
The intrinsic value of one Wanbangde Pharmaceutical Holding Group Co Ltd stock under the Base Case scenario is 8.36 CNY.
Compared to the current market price of 4.95 CNY, Wanbangde Pharmaceutical Holding Group Co Ltd is Undervalued by 41%.
You don't have any saved screeners yet
